Meta-analysis of ciltacabtagene autoleucel versus physician's choice in the treatment of patients with relapsed or refractory multiple myeloma

This article has no abstract
Epistemonikos ID: 671ed1f3562efb12ecf1d67e48111d735ec9f12e
First added on: Feb 13, 2025